Show results for
Refine by
Antigen Specific Suppliers Serving Serbia
38 companies found
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
MC-Val-Cit-PAB-duocarmycin chloride is a agent-linker conjugate for ADC with potent antitumor activity by using Duocarmycin (a DNA minor groove binding alkylating agent), linked via the ADC linker ...
based inDavis, CALIFORNIA (USA)
For over fifty years, the people of Antibodies Incorporated have dedicated themselves to supporting the life-enhancing, breakthrough work of scientists everywhere. We fulfill our mission with an extensive catalog of validated neuroscience antibodies ...
Custom antibody development is rarely "cookie cutter." Our Antibody Development Group will work with your price and technical requirements to tailor a project to your expected performance characteristics. ...
based inKitchener, ONTARIO (CANADA)
Biomatik primarily focused on Biochemicals, Enzymes, Gene Synthesis, and Peptide Synthesis services in the early years, but has since rapidly expanded its offerings to include ELISA Kits, Protein Production, Antibody Production, and Antibody ...
Species Reactivity: Pan-species (General). Host: Rabbit. Clonality: Rabbit Polyclonal. Application: WB; IHC; ICC; IP. Estimated Turnaround Time: 7-11 business ...
based inLeichhardt, AUSTRALIA
Atomo Diagnostics Limited is a global leader in the user-centered design of innovative, accurate and reliable rapid diagnostics. Atomo has developed the most consumer friendly platform available for rapid at-home testing. Our integrated testing ...
A fast, accurate point of care COVID-19 antigen test for the qualitative detection of nucleocapsid protein antigens specific to the SARS-CoV-2 virus. Utilising an anterior nasal swab specimen ...
based inSeattle, WASHINGTON (USA)
Nexelis is your partner for assay and biomarker development, advanced bioanalytical and laboratory testing, and translational immunology. As the leading specialty laboratory, we have unrivaled expertise in immunology, specifically in the areas of ...
based inGießen, GERMANY
Milenia Biotec is dedicated to the development, manufacture and sales of point-of care lateral flow tests, a technology well known from pregnancy testing. The core products of the company are based on “universal test strips”, a concept allowing ...
based inPipersville, PENNSYLVANIA (USA)
LAMPIRE specializes in custom polyclonal & monoclonal antibody development, secondary antibodies, IgGs, BSA, animal blood, tissues & organs, normal & disease state human serums & plasmas, cell media, OMNI C3 cell culture bags & contract ...
LAMPIRE began providing quality antibody support services in 1977. From antigen design and peptide synthesis to antibody purification, buffy coats (PBMCs), spleenectomies, bone marrow extractions, QC testing and labeling, our expert staff is ...
based inCounty of New Castle, DELAWARE (USA)
MedGenome Inc. is a global leader in personalized medicine with unique genomic solutions in immuno-oncology, diabetes, ophthalmology, cardiology and other rare diseases. Founded in 2013, MedGenome currently has a Next Generation Sequencing (NGS) ...
Utilizing targeted next-generation sequencing of these variable regions, can provide deeper insights into B-cell differentiation, BCR somatic hypermutation, class switching, and antigen specificity. Major ...
based inCarlsbad, CALIFORNIA (USA)
Our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated ...
based inMadison, WISCONSIN (USA)
Through a lot of hard work, a license from the Wisconsin Alumni Research Foundation (WARF) and a desire to have an impact on human health, NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the need for better ...
based inHolliston, MASSACHUSETTS (USA)
BTX has been at the forefront of electroporation technology since we introduced the first commercially available electroporator in 1983. For over 30 years, we have made it our priority to focus only on electroporation and electrofusion. This focus ...
The AgilePulse In Vivo System, used for animal immunization, vaccine development, and gene therapy, provides an intra-muscular, intra-dermal, or intra-tumor electroporation solution to produce maximum transfection efficiency. Traditional in vivo ...
based inOxford, UNITED KINGDOM
ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses. We offer unique solutions for preclinical and clinical immunology research, including a comprehensive and integrated antigen ...
Blood Processing Services for Cell-Based Assays the most critical step for successful immune monitoring projects. Getting blood processing right can be a significant challenge. Blood collection, shipping and processing is often the first point of ...
based inVirum, DENMARK
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial ...
Reliable Identification of SARS-CoV-2-Specific T-Cell Responses. T Cells Take the Lead in COVID-19. A deeper understanding of viral-specific T-cell responses to COVID-19 is needed to explore vaccine responses, ...
based inCooksbridge Lewes, UNITED KINGDOM
With over 30 years of trading experience, Quadratech Diagnostics Ltd has always been and remains committed to providing the highest quality state-of-the-art medical diagnostic and research products. With over 30 years of trading experience, ...
based inBerlin, GERMANY
JPT Peptide Technologies GmbH is a leading provider of custom peptides and innovative peptide-based services and products. We are a research and development partner for projects in immunotherapy and vaccine Development, immune monitoring, proteomics ...
Clinical peptides and PepMix Peptide Pools are increasingly needed as antigen source for clinical immune monitoring, diagnostics, cell therapy and vaccine development. The diversity of applications and regulatory requirements calls ...
based inAmsterdam, NETHERLANDS
Sanquin employs people working in many different disciplines, including donor assistants, doctors, pharmacists, researchers, laboratory technicians and production staff. Sanquin has a Supervisory Board responsible for the overall monitoring of the ...
Our proprietary technology for UV-induced MHC-peptide exchange is ideally suited for high-throughput screening of peptide-binding to the MHC class I complexes. Moreover, combinatorial coding enables fast finding of relevant peptide-specific ...
based inUppsala, SWEDEN
Abera Bioscience is a platform and vaccine development company based on over 30 years of research in the medical, molecular and microbiological field. Abera was founded in 2012 as a spin-out from the Swedish protein production company Xbrane ...
based inCambridge, UNITED ARAB EMIRATES
Founded in 2010, Sphere Fluidics is an established Life Sciences company, originally spun out from the University of Cambridge. We initially developed 25 patented products – biochips and specialist chemicals – which currently assist hundreds of ...
based inDallas, TEXAS (USA)
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology ...
based inUtrecht, NETHERLANDS
At LAVA, we are focused on applying our expertise in gamma-delta T cell engagers. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor ...
LAVA-1207, a gamma-delta bsTCE targeting the prostate specific membrane antigen (PSMA), has also demonstrated preclinical proof-of-concept. We expect to initiate a Phase I/IIa trial in metastatic ...